Latest News and Press Releases

NEWARK, DEL, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The global Alzheimer's therapeutics industry is poised for significant expansion, with market valuation estimated at USD 4,288.8 million in 2025,...

NEWARK, Del, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The estimated value of the worldwide Alzheimer's in 2023 is US$ 3,052.3 million. By 2033, the market for Alzheimer's treatments is predicted to grow at...

Fort Collins, Colorado, Oct. 09, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the Alzheimer’s therapeutics market was valued at USD 3.8 Billion in 2022 and is expected to reach USD...

Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...

Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...

Portland, OR, Nov. 06, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Alzheimer’s therapeutics market was estimated at $6.1 billion in 2021 and is...

DUBAI, United Arab Emirates, April 15, 2022 (GLOBE NEWSWIRE) -- Alzheimer’s Therapeutics is the most common reason for progressive dementia in the elderly population. There has been an exponential...